TETRALOGIC PHARMACEUTICALS CORP 4
4 · TETRALOGIC PHARMACEUTICALS CORP · Filed Jan 30, 2015
Insider Transaction Report
Form 4
Reed Douglas MD
Director
Transactions
- Award
Stock Option
2015-01-28$5.25/sh+10,000$52,500→ 30,000 totalExercise: $5.25Exp: 2025-01-28→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Beginning January 28, 2015, stock options will vest and become exercisable over the following 12 months in equal increments. Stock options are subject to the reporting person's continued service as a director as of each vesting date.